首页
400-620-6333
应用
选项
-
Recombinant IFNγ Antibody关联靶标: IFNG简短描述: Recombinant (R4-6A2); Rat anti Mouse IFNγ Antibody; Flow, in vivo/vitro IFNγ neutralization; Unconjugated种属反应性: 小鼠(Mouse) 亚型: Rat IgG1宿主种属: 大鼠(Rat) 克隆号: R4-6A2 偶联: Unconjugated
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
-
Blinatumomab (anti-CD3&CD19)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; CHO; ELISA, Flow Cytometry; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 853426-35-4
-
Epcoritamab (anti-CD3&CD20)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2134641-34-0SMILES: [Epcoritamab]
-
Faricimab (anti-ANG2&VEGFA)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry; Unconjugated种属反应性: 人(Human) 亚型: Human IgG宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1607793-29-2
-
Teclistamab (anti-CD3&BCMA)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG4SP; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2119595-80-9SMILES: [Teclistamab]
-
Vanucizumab (anti-ANG2&VEGFA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1448221-05-3SMILES: [Vanucizumab]
-
Cevostamab (anti-CD3&FCRL5)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2249888-53-5SMILES: [Cevostamab]
-
Inezetamab (anti-CD40&MSLN)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1-EM-CGC; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1-EM-CGC宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2568264-76-4
-
Tidutamab (anti-CD3&SSTR2)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2148354-90-7
-
Odronextamab (anti-CD20&CD3)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1801338-64-6SMILES: [Odronextamab]
-
Linvoseltamab (anti-BCMA&CD3)简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2408319-25-3
